A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer — Stella
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
(208 sites) United States
Los Angeles Cancer Network, Anaheim, California OPN - Oncology Physician Network (Los Alamitos), Los Alamitos, California Banner MD Anderson Cancer Center, Greeley, Colorado Advanced Research LLC, Deerfield Beach, Florida Florida Cancer Specialist - South, Fort Myers, Florida Show all 208 locations Key details Sponsor
Shanghai Henlius Biotech
Enrollment target
~550 participants
Primary completion
June 2027
Last updated February 2026